CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 11,810
-440 (-3.59%)
At close: Oct 23, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 152.41 billion as of October 23, 2026. It is the 23,967th most valuable company in the world and the 968th biggest in South Korea. Its market cap has decreased by 29.56% in one year.
Market Cap
152.41B
Enterprise Value
115.10B
Revenue
2.15B
Global Rank
Country Rank
#968 South Korea
PE Ratio
19.99
ChartMarket Cap Chart
Since October 16, 2024, CellBion's market cap has decreased from 263.06B to 152.41B, a decrease of -42.06%. That is a compound annual growth rate of -23.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 152.41B | -49.67% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC WellBeing | 201.65B |
| HEM Pharma | 200.77B |
| DAE HWA Pharmaceutical | 182.93B |
| Vivozon Pharmaceutical | 174.48B |
| NOVAREX | 164.45B |
| Kyung Dong Pharmaceutical | 143.57B |
| HYUNDAI BIOLAND | 129.75B |
| PHARMARESEARCH BIO | 121.66B |